Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 24, 2023 - Issue 10
Submit an article Journal homepage
2,918
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathy

Madeline Merkela Alnylam Pharmaceuticals, Cambridge, MA, USACorrespondence[email protected]
View further author information
,
David Danesea Alnylam Pharmaceuticals, Cambridge, MA, USAView further author information
,
Chongshu Chena Alnylam Pharmaceuticals, Cambridge, MA, USAView further author information
,
Jessie Wangb Analysis Group, Boston, MA, USAView further author information
,
Aozhou Wub Analysis Group, Boston, MA, USAView further author information
,
Hongbo Yangb Analysis Group, Boston, MA, USAView further author information
&
Hollis Lina Alnylam Pharmaceuticals, Cambridge, MA, USAView further author information
 show all
Pages 1205-1214 | Received 31 Jan 2023, Accepted 16 May 2023, Published online: 26 May 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.